Index of artpub/2022/282321/

Krolewiecki, Alejandro J
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
2022
https://ddd.uab.cat/record/282321